optimizing of the intraoperative application of fentanyl during liver transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010698

Enrollment

Registered

2016-08-31

Start date

2007-03-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K72.0

Interventions

Group 1: continuous application of fentayl with 3µg/kg/h with start at the beginning of the anaesthsia and stop with beginning of the anhepatic turn during the surgery Group 2: continuous application

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: liver transplantation

Exclusion criteria

Exclusion criteria: informed consent missing drug abuse acute kidney failure anaesthesia with using other volatila anaesthetics than isoflurane acute infection (fever or SIRS positive) > 20h cold ischemia of the donor organ

Design outcomes

Primary

Measure	Time frame
Level of fentanyl in plasma at the end of the Operation and the possibility of extubation	—

Secondary

Measure	Time frame
not availabe	—

Countries

Germany

Contacts

Public ContactUta-Carolin Pietsch

Klini und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Leipzig, AöR

uta-carolin.pietsch@medizin.uni-leipzig.de00493419717700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026